MedPath

Pharus Taiwan, Inc.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.

Recruiting
Conditions
Lung Cancer
First Posted Date
2025-09-19
Last Posted Date
2025-09-19
Lead Sponsor
Pharus Taiwan, Inc.
Target Recruit Count
1340
Registration Number
NCT07182214
Locations
🇨🇳

Pharus Taiwan, Inc., Hsinchu, Taiwan

OncoSweep Cancer Spotlight and Spectrum Product Line

Completed
Conditions
Lung Cancer
First Posted Date
2024-02-15
Last Posted Date
2025-09-17
Lead Sponsor
Pharus Taiwan, Inc.
Target Recruit Count
109
Registration Number
NCT06261294
Locations
🇨🇳

Mackay Memorial Hospital, Taipei, Zhongshan Dist, Taiwan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.